LOC399839 Inhibitors
LOC399839 inhibitors form a distinct chemical class designed to selectively target and modulate the function of the non-coding RNA LOC399839. Classified as a long intergenic non-protein coding RNA (lincRNA), LOC399839 lacks protein-coding capacity but has emerged as a critical player in the intricate landscape of cellular regulation. The inhibitors developed for LOC399839 are intricately designed to interact with the specific molecular structure of this non-coding RNA, aiming to disrupt its normal interactions within the cellular environment and potentially influence various cellular regulatory pathways.
The molecular architecture of LOC399839 inhibitors is precisely tailored to engage specific binding sites on the RNA molecule, inducing changes in its conformation and dynamics. In laboratory research, these inhibitors serve as indispensable tools, allowing scientists to probe the nuanced functions of LOC399839 in various cellular contexts. By manipulating the function of LOC399839, researchers aim to unravel the complex mechanisms of non-coding RNA-mediated regulation, contributing to a deeper understanding of the intricate network of molecular players orchestrating cellular processes and potential roles in cellular homeostasis. The study of LOC399839 inhibitors stands at the forefront of advancing our comprehension of non-coding RNA biology and the nuanced roles these molecules play in the intricate web of cellular regulatory mechanisms.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with ribosome function, potentially reducing overall protein levels. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Intercalates into DNA and prevents RNA synthesis by inhibiting RNA polymerase, thereby reducing gene expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $40.00 $210.00 $816.00 $65.00 | 394 | |
Causes premature chain termination during translation by acting as an analog of aminoacyl-tRNA. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, which is part of the regulatory pathway that affects protein synthesis and cell growth. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A cyclin-dependent kinase inhibitor that may alter cell cycle progression and influence gene expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that can lead to increased levels of proteins, potentially affecting the expression of other proteins. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
A metabolite of Vitamin A that regulates gene expression by activating nuclear receptors. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
Specifically inhibits RNA polymerase II, which is responsible for mRNA synthesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Known for its ability to inhibit RNA polymerase I, II, and III, affecting multiple pathways of gene expression. | ||||||